返回
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment
DOI:10.1016/j.jns.2005.07.019.png)
摘要
En 中文
The aim of the study was to assess neocortical changes and their relevance to cognitive impairment in early relapsing-remitting multiple sclerosis (RRMS). Conventional magnetic resonance was acquired in 41 RRMS patients and 16 demographically matched normal controls (NC). An automated analysis tool was used to obtain measures of cortical brain volumes normalized for head size. Neuropsychological performance of MS patients was assessed through the Rao's Brief Repeatable Battery. We identified 18 cognitively preserved (MS-cp) and 23 cognitively impaired (MS-ci) MS patients. Values of normalized cortical volumes (NCV) in the whole MS sample were lower than those in the NC group (p = 0.01). MS-ci patients showed NCV values lower (p = 0.02) than did both MS-cp patients and NC. Moreover, we found a positive correlation between NCV values and measures of verbal memory (r = 0.51,p = 0.02), verbal fluency (r = 0.51,p = 0.01) and attention/concentration (r = 0.65, p < 0.001) in MS-ci patients. Furthermore, NCV values were significantly decreased in patients who scored lower on a greater number of tests (r = -0.58, p < 0.01) in the MS-ci group. Only MS-ci patients bad cortical atrophy significantly correlated with a poorer neuropsychological performance. Grey matter pathology may contribute to the development of cognitive impairment in MS from the earliest stages of the disease. (c) 2006 Elsevier B.V. All rights reserved.
Keyword:
multiple sclerosis
cognitive impairment
gray matter atrophy
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.2
论文数:
2.5W
被引数:
1.9W
机构
暂无机构信息
引用论文
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
NEUROLOGY
IF8.5
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis
BRAIN
IF11.7
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment
NEUROLOGY
IF8.5

